JEWEL JOHNSON: Open Payments
NPI 1962147819 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,277 in 189 payments from 33 companies in 2025. Trend: 2023 $2,748 · 2024 $2,779 · 2025 $3,277
Food & beverage: $3,277
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $311 |
| ABBVIE INC. | 21 | $284 |
| Novo Nordisk Inc | 16 | $275 |
| AstraZeneca Pharmaceuticals LP | 14 | $271 |
| PFIZER INC. | 12 | $216 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $216 |
| Novartis Pharmaceuticals Corporation | 8 | $199 |
| Lilly USA, LLC | 11 | $175 |
| Lundbeck LLC | 12 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $143 |
Products named: REXULTI, Kerendia, LEQVIO, Ozempic, VRAYLAR, MOUNJARO, CAPLYTA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
